Wells Fargo & Company Begins Coverage on Inozyme Pharma (NASDAQ:INZY)
Wells Fargo & Company initiated coverage on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The firm issued an overweight rating and a $14.00 price objective on the stock. Several other research firms have also recently commented on INZY. Needham & Company LLC […]
More Stories
Great Western Mining (LON:GWMO) Hits New 52-Week Low – Here’s Why
Shares of Great Western Mining Co. PLC (LON:GWMO – Get Free Report) reached a new 52-week low on Tuesday ....
Chakana Copper (CVE:PERU) Shares Down 28.6% – Here’s What Happened
Chakana Copper Corp. (CVE:PERU – Get Free Report)’s stock price traded down 28.6% during trading on Tuesday . The stock...
Basic Attention Token Price Tops $0.16 on Major Exchanges (BAT)
Basic Attention Token (BAT) traded 2.1% lower against the US dollar during the one day period ending at 16:00 PM...
Flare Price Hits $0.0141 on Major Exchanges (FLR)
Flare (FLR) traded down 2.4% against the dollar during the 24-hour period ending at 16:00 PM Eastern on October 10th....
Protalex (OTCMKTS:PRTX) versus bioAffinity Technologies (NASDAQ:BIAF) Financial Analysis
bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Protalex (OTCMKTS:PRTX – Get Free Report) are both medical companies, but which...
SmarDex Price Hits $0.0079 on Top Exchanges (SDEX)
SmarDex (SDEX) traded down 4.3% against the U.S. dollar during the 24 hour period ending at 16:00 PM ET on...